RBC on Boston Scientific (BSX) Long-Range Plan Released Earlier at Investor Day, 'we are encouraged
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
JPMorgan on Boston Scientific (BSX) Investor Day Update: 'reinforces our bullish view on Boston'
September 20, 2023 10:52 AM EDTJPMorgan analyst Robbie Marcus reiterated an Overweight rating on Boston Scientific (NYSE: BSX)
The analyst comments "Management kicked off the Boston Scientific biennial analyst day with an update to its LRP (long range plan) for 2024-2026 that now points towards: (1) sales CAGR of +8-10%... More
AutoZone, Starbucks and Block fall premarket; Dell, Tesla rise
September 19, 2023 8:04 AM EDTInvesting.com -- U.S. futures traded marginally higher Tuesday, as investors await the start of the crucial two-day Federal Reserve meeting, which could set the tone for weeks to come.
Here are some of the biggest premarket U.S. stock movers today:
Instacart is set to make its Nasdaq... More
Boston Scientific (BSX) to Acquire Relievant Medsystems for Over $850 Million
September 19, 2023 7:01 AM EDTBoston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company that has developed and commercialized the Intracept® Intraosseous Nerve Ablation System to treat vertebrogenic pain, a form of chronic low back pain. The transaction includes an upfront cash payment of $850 million and undisclosed additional contingent payments based on sales performance over the next three... More
